Background : Aortic valve stenosis (AS) is the most common valvular heart disease.
A link between atherosclerosis and the development of aortic valve stenosis (AS) has been suggested. We studied cholesterol-fed rabbits receiving or not vitamin D2 and assessed their aortic valve (AV) function. Echocardiographic assessment of the aortic valve was done during treatment. Control and cholesterol-fed animals developed no abnormality of their valve. However, animals receiving cholesterol and vitamin D2 developed a significant decrease in AV area and significant increase in transvalvular gradient. This study supports a potential link between atherosclerosis and the development of AS. The differences noted between hypercholesterolemia with or without vitamin D2 imply a role for calcium.
Introduction:
Aortic valve stenosis (AS) is the most common valvular heart disease in Western countries. Considering its increasing prevalence with age, aortic valve stenosis is bound to become an ever increasing health problem in aging populations. Since AS was always considered to be simply a degenerative disease of the valve, virtually no attention was given to its potential medical treatment other than surgical replacement of the valve in severe symptomatic cases. However, many recent observations have suggested a link between the pathophysiology of the development of AS and atherosclerotic disease: in cohort studies, many traditional atherosclerotic risk factors have been associated with increasing prevalence of aortic stenosis (1-6). Therefore, many investigators now center their efforts on the hypothesis of an atherosclerosis-AS link.
Animal models of AS have been developed in the past but all of those models implied a surgical manipulation of the aortic valve per se or banding of the ascending aorta. None of these invasive animal models reproduce the true pathophysiology of native AS.
Moreover, none of these models allow the study of the evolution of neither the early phases of aortic valve disease nor the potential prevention of progression to severe stages of the disease. In this study, we report for the first time the development of AS in a rabbit model of atherosclerosis.
Methods:
Animals:
22 male New Zealand rabbits (2-2.5 kg) were divided in three study groups (six to 10 animals / group): 1) controls receiving normal rabbit chow without any dietary supplement; 2) animals fed with 0.5% cholesterol (chol)-enriched chow (Harlan, Histology: At the end of protocol, rabbits were exsanguinated under anesthesia. The ascending aorta section containing the aortic valve was dissected, rinsed in phosphatebuffered saline, embedded in OCT and snap-frozen in liquid nitrogen. Cross-sectional serial sections were prepared and Alizarin red S and von Kossa silver stains were carried out to visualize calcium deposition.
Statistics:
Results are presented as mean ± SEM unless specified otherwise. Repeated measure one-way ANOVA with post hoc Tukey's test or paired t tests were used for intragroup comparisons to assess the evolution of Ca 2+ serum levels over time. Unpaired t test was used for intergroup comparisons (Total cholesterol levels). Paired t test was used for
Results:
Cholesterol and calcium levels: Figure 1 depicts the evolution of total cholesterol as well as calcium circulatory levels in the three animal groups. Animals from group 1 displayed no modifications of those two parameters. Total cholesterol circulatory levels rose to high levels in both groups 2 and 3 ( Fig 1a) . Interestingly, vitamin D2 caused an additional increase of serum cholesterol despite similar cholesterol intake. Calcium levels were slightly more elevated in the animals from group 3. This mild difference reached statistical significance from week 8 although calcium levels were elevated throughout the protocol (Fig 1b) .
Development of atherosclerosis:
Arteries of the control group remained normal throughout the protocol. As expected based on previous observations by other groups who used this model, the animals fed with the cholesterol-enriched diets (with or without vitamin D supplements) developed severe atherosclerotic involvement of their arteries that was evident at macroscopic as well as microscopic examination (not shown).
Aortic valve:
Results for aortic valve area are summarized in Figure 2 . Baseline aortic valve areas were comparable in all three groups. When corrected for body weight gain, no significant change was noted in calculated valve area in animals in groups control and chol throughout the protocol (Fig 2, middle column) . However, animals in group chol + vit D2 behaved differently (Fig 2, bottom row) . Aortic valve area (AVA) decreased in eight out of ten animals after 12 weeks of treatment. This decrease was even more pronounced when AVAs were corrected for the animal's weight. Transvalvular gradients remained normal in groups control and chol but increased in the chol + vit D2 group significantly during the protocol as aortic valve area decreased. An example is illustrated in Figure 3 . Two-dimensional imaging of the diseased aortic valves showed an increase in the thickness and echogenicity of the leaflets as well as a reduced mobility compatible with leaflet sclerosis and areas of calcification. This is confirmed by visual inspection of excised valves as illustrated in Figure 4 . Histological examination of the diseased valves demonstrated leaflet thickening and deposition of calcium both at the aortic attachment site as well as in the leaflet body. An example of aortic valve echographic abnormalities seen in animals from group 3 compared to control animals is given in Figure 5 . Histological evidence of calcium deposition is displayed in Figure 6 .
Inter and intra-observer variability was blindly assessed on half of the animals for the echocardiographic measurement of aortic valve area by continuity equation. Intraobserver variability was less than 5% and inter-observer variability was 8%.
Discussion:
The theory of an atherosclerotic pathogenesis of AS in humans is becoming more and more popular. AS had been described many years ago in patients suffering from cholesterol metabolism abnormalities such as Tangier's disease and severe homozygous familial hypercholesterolemia (7) (8) (9) . Our model has many advantages over most of those previously described. In small animals, pressure-overload models with banding of the ascending aorta as been used to mimic the situation seen in valvular stenosis (40-44). However, this model has the disadvantage of producing a supra-coronary obstruction that is not reflective of the situation of valvular stenosis where the obstruction occurs before the implantation of the coronary arteries. In larger animals such as sheep, aortic valve stenosis has also been induced by surgical procedures. Since the disease is artificially created, it is impossible to study the physiopathology the disease on the valve as well as potential strategies for preventing or slowing the degenerative process. We have developed a model where the pathogenesis of AS is probably related to the atherogenic factors that seem to be the mechanism also suspected in human disease. All animal models have their limitations and, of course, we are aware that the animals in this protocol were submitted to extreme situations of hypercholesterolemia together with vitamin D supplementation, a combination that will not be encountered in humans. Multiple risk factors that are clearly absent from our model interact in humans to induce AS. The long-term evolution of the animals has not been assessed and we still do not know if the disease will continue to progress over time. Reversibility has not been assessed nor the effect of withdrawal of the offending factors.
Conclusions:
We report an experimental model of acquired aortic valve stenosis in rabbits fed with a high cholesterol diet and supplements of vitamin D2. These results support the hypothesis of the link between atherosclerosis and aortic valve stenosis in humans.
This experimental model may prove useful to study the early evolution of the disease, to study the effects of various atherosclerotic risk factors on this evolution or the use of pharmacological treatments to delay or even stop this evolution. 
